Home › Medulloblastoma › New Jersey
Medulloblastoma clinical trials in New Jersey
3 studies for Medulloblastoma are looking for participants at sites in New Jersey.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Saint Peter's University Hospital, New Brunswick
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
- Newark Beth Israel Medical Center, Newark
- and 1 more
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Hackensack University Medical Center, Hackensack
RecruitingPhase 2
Up to age 21 · All sexes · Updated Aug 12, 2026 · NCT04696029A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 3 to 22 · All sexes · Updated Jul 13, 2026 · NCT07698899From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.